罗欣药业(002793) - 2020 Q3 - 季度财报

Financial Performance - Net profit attributable to shareholders was CNY 128,535,584.33, an increase of 20.89% year-on-year[7] - Operating revenue for the reporting period was CNY 1,679,440,213.67, down 1.03% compared to the same period last year[7] - Basic earnings per share were CNY 0.09, a decrease of 10.00% compared to the same period last year[7] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 121,297,984.21, an increase of 19.90% year-on-year[7] - Net profit for Q3 2020 was CNY 133,939,465.90, an increase from CNY 112,344,501.03 in the same period last year[47] - The net profit for the current period was a loss of CNY 29,242,228.56, compared to a profit of CNY 70,759,586.29 in the previous period[60] - The net profit attributable to the parent company was CNY 343,615,259.70, down from CNY 399,891,881.86 in the previous period[55] Assets and Liabilities - Total assets at the end of the reporting period were CNY 7,123,469,018.73, a decrease of 4.52% compared to the end of the previous year[7] - The company's total liabilities decreased to CNY 2,785,251,732.52 from CNY 3,498,805,588.74, a reduction of approximately 20.5%[39] - The company's total equity increased to CNY 4,338,217,286.21 from CNY 3,961,754,703.94, reflecting an increase of approximately 9.5%[39] - The total assets as of September 30, 2020, were CNY 7,655,485,409.82, down from CNY 7,787,204,851.07 at the end of 2019[42] - The total liabilities decreased to CNY 51,840,318.37 from CNY 184,607,194.10[43] Cash Flow - The net cash flow from operating activities was CNY -132,618,109.85, a decrease of 157.90% year-on-year[7] - Cash received from operating activities increased by 325.23% to CNY 437,109,010.57, due to the recovery of acceptance bill deposits[18] - The company's cash flow from investment activities decreased by 81.33% to CNY 143,410,941.67, due to reduced investments in wealth management products[18] - The cash inflow from operating activities was 133,804,548.24 CNY, compared to 1,028,922,551.37 CNY in the previous period[65] - The cash outflow for operating activities totaled 75,590,736.37 CNY, down from 968,134,256.74 CNY in the previous period[65] Shareholder Information - The total number of shareholders at the end of the reporting period was 17,424[11] - The largest shareholder, Shandong Luoxin Holdings Co., Ltd., held 35.69% of the shares[11] Expenses - Sales expenses decreased by 44.01% to CNY 1,386,242,189.22, impacted by reduced promotional activities due to the pandemic[18] - Research and development expenses decreased to CNY 82,497,045.73 from CNY 104,689,036.80[46] - The company reported a decrease in sales expenses to CNY 575,318,056.48 from CNY 677,162,623.08[46] Non-Recurring Items - The company reported a total of CNY 19,817,408.23 in non-recurring gains and losses for the year-to-date[8] - The company reported no significant securities or derivative investments during the reporting period[27][28] - The company has not engaged in any major external guarantees during the reporting period[31] - The company has not reported any overdue commitments from major shareholders or related parties during the reporting period[31] Equity and Financing - Long-term borrowings increased by 78.05% to CNY 600,753,334.02, reflecting new borrowings from financial institutions[18] - The company implemented an equity incentive plan, granting a total of 33.5 million shares, representing 2.31% of the total share capital[20] - The company plans to redeem all outstanding "Dongyin Convertible Bonds" starting from November 3, 2020[24] Comprehensive Income - Other comprehensive income after tax was CNY -13,662,108.41, compared to CNY 21,110,533.86 in the previous period[47] - The total comprehensive income for the third quarter was CNY 120,277,357.49, compared to CNY 133,455,034.89 in the previous period[51] - The total comprehensive income attributable to the parent company was CNY 335,215,288.99, down from CNY 413,132,665.76 in the previous period[58]